Paul di Pasquale, DO
Otolaryngology/Facial Plastic Surgery · Wesley Chapel, FLNPI 1073559936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,750 of the $9,646 with a category attached, or 70.0%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.6%. Reporting peaked in 2022 at $3,627 and has fallen 67.0% since, to $1,199 in 2025. Among otolaryngology/facial plastic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $50.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acelrx Pharmaceuticals, Inc.$2K
- Merz North America, Inc.$2K
- Medtronic$1K
- Regeneron Healthcare Solutions, Inc.$897
- Sanofi$674
- Stryker$351
- plus $2K from 24 others
What the payments were for
- Consulting fees$2,25023%
- Travel & lodging$3444%
- Food & beverage$6,75070%
- Education$3023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acelrx Pharmaceuticals, Inc. | 2 | $2,272 |
| Merz North America, Inc. | 19 | $2,033 |
| Medtronic(2 entities) | 30 | $1,145 |
| Regeneron Healthcare Solutions, Inc. | 17 | $897 |
| Sanofi | 16 | $674 |
| Stryker | 11 | $351 |
| Intersect ENT, Inc. | 6 | $339 |
| Kaleo, Inc. | 18 | $296 |
| GSK | 8 | $261 |
| Pfizer | 21 | $170 |
| Inspire Medical Systems, Inc. | 2 | $148 |
| Smith+Nephew | 2 | $127 |
| Hologic Sales And Service, LLC | 1 | $105 |
| Phadia US Inc. | 5 | $97 |
| Aerin Medical Inc. | 5 | $86 |
| Optinose US, Inc. | 4 | $82 |
| Amgen | 3 | $77 |
| Genentech USA, Inc. | 3 | $76 |
| Integra Lifesciences Corporation | 2 | $58 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Abbott | 1 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $45 |
| Alk-abello, Inc | 3 | $42 |
| Hikma Pharmaceuticals USA | 2 | $40 |
| Itamar Medical Inc | 1 | $32 |
| Neurent Medical Limited | 1 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Apria Healthcare LLC | 1 | $17 |
| AbbVie | 1 | $16 |
| Acclarent, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DSUVIA$2,250
- XEOMIN$1,205
- DUPIXENT$601
- ASCLERA$465
- FUSION$344
- FIAGON NAVIGATION UNIT$164
- NIM Vital$150
- STEALTH AUTOGUIDE SYSTEM$136
- NUCALA$123
- SINUVA$111
- TULA$107
- CoolSeal Generator$105
How this compares
$9,646 in reported general payments places this provider in the 95th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.
See all otolaryngology/facial plastic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 199 | $5,616 |
| Epinephrine | 28 | $5,247 |
| Fluocinolone Acetonide Oil | 36 | $1,875 |
| Fluorouracil | 18 | $1,249 |
| Famotidine | 96 | $1,162 |
| Azelastine Hcl | 24 | $870 |
| Omeprazole | 67 | $842 |
| Fluticasone Propionate | 61 | $772 |
| SynthroidLevothyroxine Sodium | 15 | $725 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $642 |
| Diclofenac Sodium | 13 | $401 |
| Pantoprazole Sodium | 21 | $389 |
| Levocetirizine Dihydrochloride | 33 | $353 |
| Imiquimod | 17 | $340 |
| Mupirocin | 41 | $316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $40 | $5,24728 claims |
| AbbVieSynthroid | $16 | $72515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.
Other otolaryngology/facial plastic surgery in Wesley Chapel
- Jeffery MagnusonCelebration$37K
- Ryan GeggSanta Rosa Beach$11K
- David GerthMiami$9K
- Michael SeidmanCelebration$9K
- Maria ComptonPort Charlotte$7K
- David CarlsonJacksonville$6K
- Janet LeeTampa$5K
- Melyssa HancockBoca Raton$5K
- Todd ParnesDelray Beach$5K
- Joseph DerbyshireZephyrhills$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.